| ORIGINAL_SOURCE | SAMPLE_ALIAS | IHEC_REFERENCE_EPIGENOME_IDENTIFIER | SAMPLE_ACCESSION | SAMPLE_TITLE | ANONYMIZED_NAME | BATCH | BIOMATERIAL_PROVIDER | BIOMATERIAL_TYPE | COMMON_NAME | DIFFERENTIATION_METHOD | DIFFERENTIATION_STAGE | DISEASE | ENA-CHECKLIST | LINE | LINEAGE | MEDIUM | MOLECULE | PASSAGE | SAMPLE_DESCRIPTION | SCIENTIFIC_NAME | SEX | TAXON_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CEMT_7 | CEMT0007.gDNA | CEMT0007 | EGAN00001172015 | CEMT_7, MCF10A, Mammary gland-Breast with pathology Mammary gland-Breast Fibrocystic Disease, genomic DNA | MCF10A | 1 | Aparicio | Cell Line | human | NA | NA | Mammary gland-Breast Fibrocystic Disease | ERC000026 | MCF10A | A basal-like human breast cancer cell line | Growth media: DMEM/F12 +5% horse serum (it also includes FGF (20 ug/ml), Hydrocortizone (0.5 mg/ml), Cholera Toxin (10 ug/ml), insulin (1 mg/ml), Pen/Strep 1%) | genomic DNA | 3 | External Identifier:SA335, Original Source Name:CEMT_7, Anatomic Site:Mammary gland-Breast, Pathology Alias:Mammary gland-Breast Fibrocystic Disease, Cell Line Name:MCF10A, Original Source Id:34134 | Homo sapiens | Female | 9606 |
| CEMT_8 | CEMT0008.gDNA | CEMT0008 | EGAN00001172016 | CEMT_8, 184-hTert-L9, anatomic_site:Mammary gland-Breast, normal, genomic DNA | 184-hTert-L9 | 1 | Aparicio | Cell Line | human | NA | NA | None | ERC000026 | 184-hTert-L9 | Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. | Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA | genomic DNA | 11 | External Identifier:SA039, Original Source Name:CEMT_8, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L9, Original Source Id:34135 | Homo sapiens | Female | 9606 |
| CEMT_9 | CEMT0009.gDNA | CEMT0009 | EGAN00001172017 | CEMT_9, 184-hTert-L2, Mammary gland-Breast, Normal, genomic DNA | 184-hTert-L2 | 1 | Aparicio | Cell Line | human | NA | NA | None | ERC000026 | 184-hTert-L2 | Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. | Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA | genomic DNA | 12 | External Identifier:SA040, Original Source Name:CEMT_9, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L2, Original Source Id:34136 | Homo sapiens | Female | 9606 |
| CEMT_7 | CEMT0007.tRNA | CEMT0007 | EGAN00001176008 | CEMT_7, MCF10A, Mammary gland-Breast with pathology Mammary gland-Breast Fibrocystic Disease, total RNA | MCF10A | 1 | Aparicio | Cell Line | human | NA | NA | Mammary gland-Breast Fibrocystic Disease | ERC000026 | MCF10A | A basal-like human breast cancer cell line | Growth media: DMEM/F12 +5% horse serum (it also includes FGF (20 ug/ml), Hydrocortizone (0.5 mg/ml), Cholera Toxin (10 ug/ml), insulin (1 mg/ml), Pen/Strep 1%) | total RNA | 3 | External Identifier:SA335, Original Source Name:CEMT_7, Anatomic Site:Mammary gland-Breast, Pathology Alias:Mammary gland-Breast Fibrocystic Disease, Cell Line Name:MCF10A, Original Source Id:34134 | Homo sapiens | Female | 9606 |
| CEMT_8 | CEMT0008.tRNA | CEMT0008 | EGAN00001176009 | CEMT_8, 184-hTert-L9, Mammary gland-Breast, normal, total RNA | 184-hTert-L9 | 1 | Aparicio | Cell Line | human | NA | NA | None | ERC000026 | 184-hTert-L9 | Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. | Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA | total RNA | 11 | External Identifier:SA039, Original Source Name:CEMT_8, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L9, Original Source Id:34135 | Homo sapiens | Female | 9606 |
| CEMT_9 | CEMT0009.tRNA | CEMT0009 | EGAN00001176010 | CEMT_9, 184-hTert-L2, Mammary gland-Breast, Normal, total RNA | 184-hTert-L2 | 1 | Aparicio | Cell Line | human | NA | NA | None | ERC000026 | 184-hTert-L2 | Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. | Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA | total RNA | 12 | External Identifier:SA040, Original Source Name:CEMT_9, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L2, Original Source Id:34136 | Homo sapiens | Female | 9606 |
| ORIGINAL_SOURCE | SAMPLE_ALIAS | IHEC_REFERENCE_EPIGENOME_IDENTIFIER | SAMPLE_ACCESSION | SAMPLE_TITLE | ANONYMIZED_NAME | BIOMATERIAL_PROVIDER | BIOMATERIAL_TYPE | COLLECTION_METHOD | COMMON_NAME | DISEASE | DONOR_AGE | DONOR_ETHNICITY | DONOR_HEALTH_STATUS | DONOR_ID | DONOR_SEX | MOLECULE | REFERENCE_BIOSAMPLE_URI | SAMPLE_DESCRIPTION | SCIENTIFIC_NAME | TAXON_ID | TISSUE_DEPOT | TISSUE_TYPE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CEMT_45 | CEMT0045.gDNA | CEMT0045 | Primary Tissue from SW-TTP-177 (55, Male, Diseased Thyroid sample with donor health condition: Thyroid Goiter) | SW-TTP-177 | Wiseman lab | Primary Tissue | Gross Dissection | human | Thyroid Goiter | 55 | Unknown | Thyroid Goiter | SW-TTP-177 | Male | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-177 (55, Male, Diseased Thyroid sample with donor health condition: Thyroid Goiter) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid | |
| CEMT_44 | CEMT0044.gDNA | CEMT0044 | Primary Tissue from SW-TTP-177 (55, Male, Normal Thyroid sample with donor health condition: Thyroid Goiter) | SW-TTP-177 | Wiseman lab | Primary Tissue | Gross Dissection | human | None | 55 | Unknown | SW-TTP-177 | Male | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-177 (55, Male, Normal Thyroid sample with donor health condition: Thyroid Goiter) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid | ||
| CEMT_43 | CEMT0043.gDNA | CEMT0043 | Primary Tissue from SW-TTP-170 (46, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) | SW-TTP-170 | Wiseman lab | Primary Tissue | Gross Dissection | human | Thyroid Adenoma-Follicular | 46 | Unknown | Thyroid Adenoma-Follicular | SW-TTP-170 | Female | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-170 (46, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid | |
| CEMT_42 | CEMT0042.gDNA | CEMT0042 | Primary Tissue from SW-TTP-170 (46, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) | SW-TTP-170 | Wiseman lab | Primary Tissue | Gross Dissection | human | None | 46 | Unknown | SW-TTP-170 | Female | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-170 (46, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid | ||
| CEMT_4 | CEMT0040.gDNA | CEMT0040 | Primary Tissue from SW-TTP-156 (67, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) | SW-TTP-156 | Wiseman lab | Primary Tissue | Gross Dissection | human | None | 67 | Unknown | SW-TTP-156 | Female | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-156 (67, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid | ||
| CEMT_41 | CEMT0041.gDNA | CEMT0041 | Primary Tissue from SW-TTP-156 (67, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) | SW-TTP-156 | Wiseman lab | Primary Tissue | Gross Dissection | human | Thyroid Adenoma-Follicular | 67 | Unknown | Thyroid Adenoma-Follicular | SW-TTP-156 | Female | genomic DNA | __TO_BE_GENERATED__ | Primary Tissue from SW-TTP-156 (67, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab | Homo sapiens | 9606 | Thyroid | Thyroid |
| ORIGINAL_SOURCE | SAMPLE_ALIAS | SAMPLE_ACCESSION | SAMPLE_TITLE | ANONYMIZED_NAME | BIOMATERIAL_PROVIDER | BIOMATERIAL_TYPE | CELL_TYPE | COMMON_NAME | DISEASE | DONOR_AGE | DONOR_ETHNICITY | DONOR_HEALTH_STATUS | DONOR_ID | DONOR_SEX | ENA-CHECKLIST | IHEC REFERENCE EPIGENOME IDENTIFIER | MARKERS | MOLECULE | PASSAGE_IF_EXPANDED | SAMPLE_DESCRIPTION | SCIENTIFIC_NAME | TAXON_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CEMT_1 | CEMT0001.gDNA | EGAN00001172011 | CEMT_1, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 230-56 | Connors/Weng/Eaves Lab | Primary Cell | CD19+ cells (B lymphocytes) | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 78 | Caucasian | Diseased | 230-56 | Male | ERC000026,ERC000026 | CEMT0001 | CD19+ | genomic DNA | NA | External Identifier:B32840, Original Source Name:CEMT_1, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:230-56, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:30730 | Homo sapiens | 9606 |
| CEMT_4 | CEMT0004.gDNA | EGAN00001172012 | CEMT_4, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 231-73 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 74 | Caucasian | Diseased | 231-73 | Male | ERC000026,ERC000026 | CEMT0004 | CD19+ | genomic DNA | NA | External Identifier:B32942, Original Source Name:CEMT_4, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-73, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33649 | Homo sapiens | 9606 |
| CEMT_5 | CEMT0005.gDNA | EGAN00001172013 | CEMT_5, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 231-74 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 68 | Caucasian | Diseased | 231-74 | Female | ERC000026,ERC000026 | CEMT0005 | CD19+ | genomic DNA | NA | External Identifier:B32943, Original Source Name:CEMT_5, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-74, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33650 | Homo sapiens | 9606 |
| CEMT_6 | CEMT0006.gDNA | EGAN00001172014 | CEMT_6,Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 232-14 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 60 | Caucasian | Diseased | 232-14 | Male | ERC000026,ERC000026 | CEMT0006 | CD19+ | genomic DNA | NA | External Identifier:B32974, Original Source Name:CEMT_6, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:232-14, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33651 | Homo sapiens | 9606 |
| CEMT_1 | CEMT0001.tRNA | EGAN00001176004 | CEMT_1, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA | 230-56 | Connors/Weng/Eaves Lab | Primary Cell | CD19+ cells (B lymphocytes) | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 78 | Caucasian | Diseased | 230-56 | Male | ERC000026 | CEMT0001 | CD19+ | total RNA | NA | External Identifier:B32840, Original Source Name:CEMT_1, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:230-56, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:30730 | Homo sapiens | 9606 |
| CEMT_4 | CEMT0004.tRNA | EGAN00001176005 | CEMT_4, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA | 231-73 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 74 | Caucasian | Diseased | 231-73 | Male | ERC000026 | CEMT0004 | CD19+ | total RNA | NA | External Identifier:B32942, Original Source Name:CEMT_4, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-73, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33649 | Homo sapiens | 9606 |
| CEMT_5 | CEMT0005.tRNA | EGAN00001176006 | CEMT_5, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA | 231-74 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 68 | Caucasian | Diseased | 231-74 | Female | ERC000026 | CEMT0005 | CD19+ | total RNA | NA | External Identifier:B32943, Original Source Name:CEMT_5, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-74, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33650 | Homo sapiens | 9606 |
| CEMT_6 | CEMT0006.tRNA | EGAN00001176007 | CEMT_6, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA | 232-14 | Connors/Weng/Eaves Lab | Primary Cell | B cells | human | Blood-Peripheral Leukemia-Chronic lymphocytic leukemia | 60 | Caucasian | Diseased | 232-14 | Male | ERC000026 | CEMT0006 | CD19+ | total RNA | NA | External Identifier:B32974, Original Source Name:CEMT_6, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:232-14, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33651 | Homo sapiens | 9606 |